Viewing Study NCT00079768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-24 @ 9:21 PM
Study NCT ID: NCT00079768
Status: COMPLETED
Last Update Posted: 2010-06-17
First Post: 2004-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myositis, Inclusion Body View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inflammation View
None Myositis View
None Humanized Monoclonal Antibody View
None Cytotoxic T Cells View
None Endomysial T Cells View
None Alemtuzumab View
None Monoclonal Antibodies View
None IBM View
None Anti-CD 52 View
None Inclusion Body Myositis View